Praxis Medical Insights: Syphilis Diagnosis and Management

Syphilis remains a persistent sexually transmitted infection that requires rigorous diagnosis and management to prevent transmission, progression, and severe complications. This guideline distilled by Praxis Medical Insights outlines the current consensus from the Centers for Disease Control and Prevention (CDC) and related professional bodies on optimal screening methods, diagnostic interpretations, and treatment regimens. Key points include: the use of treponemal screening tests followed by confirmation with TP-PA to avoid false positives; recognition that non-reactive TP-PA after a reactive screening test usually suggests a false positive result; and the necessity for clinical correlation in interpreting discordant test results. Treatment protocols differ by stage: early syphilis is treated with a single dose of benzathine penicillin G, while late syphilis or neurosyphilis require longer treatment courses, potentially with intravenous antibiotics. Special populations, such as those allergic to penicillin (for whom doxycycline or other alternatives are recommended) and pregnant patients (for whom penicillin remains the only FDA-recommended treatment), are also addressed. The document emphasizes rigorous follow-up: quantitative non-treponemal tests (e.g., RPR) should be repeated at 3, 6, 9, and 12 months post-treatment, with a fourfold decline in titers signifying successful therapy. In patients with HIV co-infection or immunocompromise, closer monitoring is urged. The guideline serves as a concise reference for clinicians to ensure effective syphilis management in diverse patient populations.